ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR Convergence 2020

Abstract Number: 0937

Late Cardiovascular Outcomes in Children with Kawasaki Disease: A Population-based Cohort Study

Cal Robinson1, Rahul Chanchlani1, Anastasia Gayowsky2, Sandeep Brar3, Elizabeth Darling4, Catherine Demers4, Tapas Mondal1, Rulan Parekh5, Hsien Seow4 and Michelle Batthish1, 1McMaster Children's Hospital, Hamilton, ON, Canada, 2ICES McMaster, Hamilton, ON, Canada, 3University of California, San Fransisco, 4McMaster University, Hamilton, ON, Canada, 5University of Toronto, Toronto, Canada

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR Convergence 2020

Keywords: Administrative Data, Cardiovascular, Cohort Study, Pediatric rheumatology, Vasculitis

Session Information

Date: Saturday, November 7, 2020

Title: Plenary Session II (0934–0939)

Session Type: Plenary Session

Session Time: 11:30AM-1:00PM

Background/Purpose: Kawasaki disease (KD) is a common childhood vasculitis associated with coronary artery aneurysms (CAA). Based on our recent work, the incidence of KD has significantly increased in Ontario over the past two decades. However, the risk of long-term cardiovascular events in children without large CAA remains unknown. Our objectives were to: 1) determine the risk and timing of long-term cardiovascular events (diagnoses and procedures) among KD survivors; and 2) determine the risk of all-cause mortality.

Methods: We identified all children (0-18yr) surviving hospitalization with a KD diagnosis in Ontario between 1995-2018, through validated algorithms using population health administrative databases. We included only the first eligible hospitalization and excluded children previously diagnosed with KD and non-residents. KD cases were matched to 100 non-exposed controls by age, sex and index year. Follow-up continued until death or March 2019 (maximum 24 years). We determined incidence rates (per 1000 person-years (py)) and unadjusted hazard ratios (HR) for cardiovascular events, major adverse cardiac events (MACE; cardiovascular death, myocardial infarction (MI) or stroke composite) and all-cause mortality, comparing KD and non-exposed cohorts during the following time periods: 0-1yr, 1-5yr, 5-10yr and >10yr.

Results: Among 4,597 KD survivors, 746 (16.2%) experienced cardiovascular events, 79 (1.7%) MACE and 9 (0.2%) died during median 11.1-year follow-up (Table 1). The most frequent cardiovascular events among KD survivors were ischemic heart disease (231 children, 4.6 events/1000py), arrhythmias (229, 4.5/1000py), hypertension (159, 3.1/1000py) and peripheral vascular disease (107, 2.1/1000py). KD survivors were at increased risk of cardiovascular events and MACE vs. non-exposed children between 0-1yr, 1-5yr and 5-10yr, and cardiovascular events at >10yr follow-up (Table 1). KD survivors experienced cardiovascular events sooner than non-exposed children (Figure 1; Kaplan-Meier curve, log-rank p< 0.0001). Their risk of cardiovascular events was highest in the first year post-discharge (HR 14.13 [12.57-15.89]). KD survivors were at increased risk of undergoing percutaneous coronary intervention or coronary artery bypass grafting throughout follow-up (KD: 12 (0.3%) vs. non-exposed: 63 (0.01%), HR 14.68 [7.73-27.88]). KD survivors were at lower risk of mortality throughout follow-up (KD: 9 (0.2%) vs. non-exposed: 2,012 (0.4%), HR 0.42 [0.22-0.81]).

Conclusion: Children diagnosed with KD remain at increased risk of cardiovascular events for >10 years after index hospitalization. Despite the prevalence of cardiovascular disease, they have a lower risk of long-term mortality. Our findings highlight the need for cardiovascular disease surveillance and risk reduction strategies among KD survivors.

Table 1. Incidence and risk of cardiovascular events, comparing KD vs. non-exposed children at 0-1yr, 1-5yr, 5-10yr and >10yr follow-up

Figure 1. Composite cardiovascular event-free survival among KD survivors vs. non-exposed children

Figure 2. Patient survival among KD survivors vs. non-exposed children


Disclosure: C. Robinson, None; R. Chanchlani, None; A. Gayowsky, None; S. Brar, None; E. Darling, None; C. Demers, None; T. Mondal, None; R. Parekh, None; H. Seow, None; M. Batthish, Abbvie, 2.

To cite this abstract in AMA style:

Robinson C, Chanchlani R, Gayowsky A, Brar S, Darling E, Demers C, Mondal T, Parekh R, Seow H, Batthish M. Late Cardiovascular Outcomes in Children with Kawasaki Disease: A Population-based Cohort Study [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/late-cardiovascular-outcomes-in-children-with-kawasaki-disease-a-population-based-cohort-study/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/late-cardiovascular-outcomes-in-children-with-kawasaki-disease-a-population-based-cohort-study/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology